Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Baudax Bio, Inc is a biotechnology business based in the US. Baudax Bio shares (BXRX) are listed on the NASDAQ and all prices are listed in US Dollars. Baudax Bio employs 57 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | $0.97 - $4.95 |
---|---|
50-day moving average | $1.32 |
200-day moving average | $1.46 |
Wall St. target price | $4.67 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-3.59 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | $493,000 |
---|---|
Gross profit TTM | $-1,239,000 |
Return on assets TTM | -55.01% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | $76.1 million |
TTM: trailing 12 months
There are currently 3.9 million Baudax Bio shares held short by investors – that's known as Baudax Bio's "short interest". This figure is 55.5% up from 2.5 million last month.
There are a few different ways that this level of interest in shorting Baudax Bio shares can be evaluated.
Baudax Bio's "short interest ratio" (SIR) is the quantity of Baudax Bio shares currently shorted divided by the average quantity of Baudax Bio shares traded daily (recently around 2.7 million). Baudax Bio's SIR currently stands at 1.41. In other words for every 100,000 Baudax Bio shares traded daily on the market, roughly 1410 shares are currently held short.
However Baudax Bio's short interest can also be evaluated against the total number of Baudax Bio shares, or, against the total number of tradable Baudax Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Baudax Bio's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Baudax Bio shares in existence, roughly 60 shares are currently held short) or 0.0565% of the tradable shares (for every 100,000 tradable Baudax Bio shares, roughly 57 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Baudax Bio.
Find out more about how you can short Baudax Bio stock.
We're not expecting Baudax Bio to pay a dividend over the next 12 months.
Baudax Bio, Inc. , a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. .
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.